Skip to main content

Month: September 2023

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV

MELBOURNE, Australia, Sept. 01, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health, wellness and serious disease is pleased to advise that RedChip Companies will air interviews with Genetic Technologies Limited (Nasdaq: GENE) and 60 Degrees Pharmaceuticals (60P) (NASDAQ: SXTP) on The RedChip Money Report®, a sponsored program on Bloomberg TV, this Saturday, September 2, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S. Access the interviews in their entirety at: •  Genetic Technologies (Nasdaq: GENE): https://www.redchip.com/stocks/GENE •  60 Degrees Pharmaceuticals (NASDAQ: SXTP): https://www.redchip.com/stocks/SXTP About The RedChip Money Report®The RedChip Money...

Continue reading

Optimum Ventures Announces Securityholder Approval of Plan of Arrangement With Blackwolf Copper and Gold Ltd.

VANCOUVER, British Columbia, Sept. 01, 2023 (GLOBE NEWSWIRE) — Optimum Ventures Ltd. (“Optimum” or the “Company”) (TSXV: OPV) is pleased to announce that Blackwolf Copper and Gold Ltd.’s (“Blackwolf“) proposed acquisition of all of the outstanding securities of the Company by plan of arrangement (the “Arrangement“) was overwhelmingly approved at the Company’s annual general and special meeting of securityholders held on August 31, 2023 (the “Meeting“). At the Meeting, Optimum securityholders were asked to consider and approve a special resolution regarding the proposed Arrangement (the “Arrangement Resolution“). No dissents were received by the Company and the Arrangement Resolution was approved by 100% of the votes cast by Optimum securityholders at the Meeting. Pursuant...

Continue reading

C3is Inc. reports second quarter and six months 2023 financial and operating results

ATHENS, Greece, Sept. 01, 2023 (GLOBE NEWSWIRE) — C3is Inc. (Nasdaq: CISS) (the “Company”), a ship-owning company providing drybulk and tanker seaborne transportation services, announced today its unaudited financial and operating results for the second quarter and six months ended June 30, 2023. These financial results were based on the accounts of C3is Inc. and its wholly owned subsidiaries, which were prepared using the historical carrying costs of the assets and the liabilities of the subsidiaries from their dates of incorporation. OPERATIONAL AND FINANCIAL HIGHLIGHTSOur two handysize dry bulk carriers are currently on time charters of short term durations, producing steady cash flows. Both handysize dry vessels are unencumbered. Fleet operational utilization of 90.1% for the six months period ended June 30, 2023, as our...

Continue reading

Turnover of Apranga Group in August 2023

The retail turnover (including VAT) of Apranga Group amounted to EUR 29.4 million in August 2023 and increased by 8.6% compared to August 2022. The turnover of August 2023 is the highest monthly turnover Apranga Group has ever reached. In January through August 2023, the retail turnover of Apranga Group (including VAT) totalled EUR 204.5 million and was by 13.7% higher than in 2022. In January-August 2023, the retail turnover of Apranga Group in Lithuania increased by 13.5% year-to-year, in Latvia increased by 12.2% and in Estonia increased by 17.0%. Currently Apranga Group operates the chain of 164 stores (97 in Lithuania, 43 in Latvia and 24 in Estonia) covering the gross area of 88.5 thousand sq. m., or by 2.2% less than a year ago. Rimantas Perveneckas„Apranga“ Group General Manager+370 5 2390801

Continue reading

Urbana Corporation – Renewal Of Normal Course Issuer Bid

/NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S./ TORONTO, Sept. 01, 2023 (GLOBE NEWSWIRE) — Urbana Corporation (“Urbana”) (TSX & CSE: URB & URB.A) announced today that the Toronto Stock Exchange (“TSX”) has accepted its notice of intention to conduct a normal course issuer bid to enable it to purchase up to 3,107,298 of its non-voting Class A shares (the “Class A Shares”), representing 10% of the public float, pursuant to TSX rules (the “Notice”). Purchases under the bid may commence on September 7, 2023, and will terminate on the earlier of September 6, 2024, the date Urbana completes its purchases pursuant to the notice of intention to make a normal course issuer bid filed with the TSX, and the date of notice by Urbana of termination of the bid. Purchases will be made on the open market...

Continue reading

Globus Medical Completes Merger with NuVasive

—Creates leading global musculoskeletal company——Robust portfolio well-positioned for long-term growth and continued innovation— AUDUBON, Pa., Sept. 01, 2023 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with NuVasive, Inc. The combined company will provide surgeons and patients with one of the most comprehensive offerings of musculoskeletal procedural solutions and enabling technologies to impact the care continuum. “We’re thrilled to begin our journey together to create a leading global musculoskeletal company,” said Dan Scavilla, president and chief executive officer of Globus Medical. “With a relentless focus on changing patient lives, we’re combining our differentiated portfolios and talented teams to reach...

Continue reading

CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients

Results from pivotal study published in Diagnostics journal Confirmation of utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher disease Could predict clinical course of patients and improve personalized careCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 01, 2023 (GLOBE NEWSWIRE) — CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced data confirming the utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher disease (GD). The findings from this landmark study which were published in Diagnostics in a paper titled, “Insights into the value of lyso-Gb1 as a predictive biomarker in treatment-naïve patients with Gaucher disease type 1 in the LYSO-PROOF study,” also...

Continue reading

Nine Mile Metals Appoints Mr. Kevin Hicks as Director

VANCOUVER, British Columbia, Sept. 01, 2023 (GLOBE NEWSWIRE) — NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”) is pleased to announce that the Company has appointed Mr. Kevin Hicks to the Board of Directors. Mr. Hicks is a very successful oil and gas industry professional for 38 years in Texas and Oklahoma.  Early in his career, he designed and implemented numerous groundbreaking data acquisition and control technologies.  He then moved on to large project management, primarily in the area of data management. Kevin has a Patent for data systems technology in the oil and gas sector. Kevin is the current CEO of Have Blue Capital Corp., an investment corporation focused on Critical Mineral Investments in Canada, US, and South America. Kevin holds a Masters of Electrical Engineering from Oklahoma...

Continue reading

Xunlei Announces Changes of Board of Directors

SHENZHEN, China, Sept. 01, 2023 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei”) (Nasdaq: XNET), a leading innovator in shared cloud computing and blockchain technology in China, today announced the resignation of Mr. Sean Shenglong Zou and Mr. Hui Duan as directors of the Company for personal reasons from August 31, 2023. Mr. Jinbo Li, Chairman and Chief Executive Officer of Xunlei, stated “On behalf of the board of directors and the management of the Company, I wish to express my appreciation of Mr. Zou and Mr. Duan and their contributions to the Company and wish them the very best in their future endeavors.” “Sean, founder of Xunlei, has played a pivotal role in Xunlei’s development over the past two decades, successfully making the Company the largest internet download service provider in the world. His unsurpassed passion,...

Continue reading

Gentex Announces Third Quarter 2023 Cash Dividend

ZEELAND, Mich., Sept. 01, 2023 (GLOBE NEWSWIRE) —  Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected car, dimmable glass, and fire protection technologies, today announced that its Board of Directors recently declared a quarterly cash dividend of $0.12 (12 cents) per share that will be payable October 18, 2023, to shareholders of record of the common stock at the close of business on October 6, 2023. About the CompanyFounded in 1974, Gentex Corporation (The NASDAQ Global Select Market: GNTX) is a supplier of automatic-dimming rearview mirrors and electronics to the automotive industry, dimmable aircraft windows for aviation markets, and fire protection products to the fire protection market. Visit the Company’s websites at www.gentex.com, fulldisplaymirror.com, and gentextech.com. Contact...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.